BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Antony Aziz, Rebecca Reynolds, Azhar Ansari. Process and Systems: A population-based model of care for people with inflammatory bowel disease – patient-reported outcomesFuture Healthcare Journal 2019; 6(1): 30 doi: 10.7861/futurehosp.6-1-30
2
Hui-Jing Zhang, Yi-Ning Zhang, Huan Zhou, Lin Guan, Yue Li, Ming-Jun Sun. IL-17A Promotes Initiation and Development of Intestinal Fibrosis Through EMTDigestive Diseases and Sciences 2018; 63(11): 2898 doi: 10.1007/s10620-018-5234-x
3
Noam Jacob, Stephan R Targan, David Q Shih. Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBDUnited European Gastroenterology Journal 2016; 4(4): 531 doi: 10.1177/2050640616649356
4
Mônica O. Belém, Giovana M.M. de Andrade, Thalita M. Carlos, Carla F.S. Guazelli, Victor Fattori, Dari O. Toginho Filho, Ivan F.L. Dias, Waldiceu A. Verri, Eduardo J.A. Araújo. Light-emitting diodes at 940 nm attenuate colitis-induced inflammatory process in miceJournal of Photochemistry and Photobiology B: Biology 2016; 162: 367 doi: 10.1016/j.jphotobiol.2016.07.008
5
Yunhai Li, Ping Chen, Jiazheng Sun, Jing Huang, Hongtao Tie, Liangliang Li, Hongzhong Li, Guosheng Ren. Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel diseaseScientific Reports 2016; 6(1) doi: 10.1038/srep33550
6
Noam Jacob, Jonathan P. Jacobs, Kotaro Kumagai, Connie W. Y. Ha, Yoshitake Kanazawa, Venu Lagishetty, Katherine Altmayer, Ariel M. Hamill, Aimee Von Arx, R. Balfour Sartor, Suzanne Devkota, Jonathan Braun, Kathrin S. Michelsen, Stephan R. Targan, David Q. Shih. Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiomeMucosal Immunology 2018; 11(5): 1466 doi: 10.1038/s41385-018-0055-y
7
Palle Bager, Susanna Jäghult. Adherence in inflammatory bowel disease (IBD): a clinical reviewGastrointestinal Nursing 2019; 17(6): 24 doi: 10.12968/gasn.2019.17.6.24
8
Lars F. Hansen, Christian Jakobsen, Anders Paerregaard, Niels Qvist, Vibeke Wewer. Surgery and Postoperative Recurrence in Children With Crohn DiseaseJournal of Pediatric Gastroenterology and Nutrition 2015; 60(3): 347 doi: 10.1097/MPG.0000000000000616
9
Florian Rieder, Giovanni Latella, Fernando Magro, Elif S. Yuksel, Peter D. R. Higgins, Antonio Di Sabatino, Jessica R. de Bruyn, Jordi Rimola, Jorge Brito, Dominik Bettenworth, Gert van Assche, Willem Bemelman, Andre d’Hoore, Gianluca Pellino, Axel U. Dignass. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s DiseaseJournal of Crohn's and Colitis 2016; 10(8): 873 doi: 10.1093/ecco-jcc/jjw055
10
Rajmohan Dharmaraj, Melodee Nugent, Pippa Simpson, Marjorie Arca, Bhaskar Gurram, Steven Werlin. Outcomes after fecal diversion for colonic and perianal Crohn disease in childrenJournal of Pediatric Surgery 2018; 53(3): 472 doi: 10.1016/j.jpedsurg.2017.08.011
11
Christine Sturm, Anika E. Wagner. Brassica-Derived Plant Bioactives as Modulators of Chemopreventive and Inflammatory Signaling PathwaysInternational Journal of Molecular Sciences 2017; 18(9): 1890 doi: 10.3390/ijms18091890
12
Rachel L Randell, Ajay S Gulati, Suzanne F Cook, Christopher F Martin, Wenli Chen, Elizabeth L Jaeger, Alexi A Schoenborn, Patricia V Basta, Hendrik Dejong, Jingchun Luo, Marisa Gallant, Robert S Sandler, Millie D Long, Michael D Kappelman. Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility StudyJMIR Research Protocols 2016; 5(1): e3 doi: 10.2196/resprot.5171
13
Gianluca Pellino, Pierlorenzo Pallante, Francesco Selvaggi. Novel biomarkers of fibrosis in Crohn’s diseaseWorld Journal of Gastrointestinal Pathophysiology 2016; 7(3): 266-275 doi: 10.4291/wjgp.v7.i3.266
14
Wee Khoon Ng, Siew C. Ng. Fibrostenotic Inflammatory Bowel Disease2018; : 5 doi: 10.1007/978-3-319-90578-5_2
15
Ersilia M. DeFilippis, Randy Longman, Michael Harbus, Kyle Dannenberg, Ellen J. Scherl. Crohn’s Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted TherapiesCurrent Gastroenterology Reports 2016; 18(3) doi: 10.1007/s11894-016-0487-z
16
Andreas Sturm. Inflammatory Bowel Disease Nursing Manual2019; : 75 doi: 10.1007/978-3-319-75022-4_10
17
Bobby Lo, Mette Julsgaard, Marianne Kajbæk Vester-Andersen, Ida Vind, Johan Burisch. Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability indexEuropean Journal of Gastroenterology & Hepatology 2018; 30(10): 1130 doi: 10.1097/MEG.0000000000001199
18
Sandra Cristina Dias dos Santos, Laura Elisabete Ribeiro Barbosa. Crohn's disease: risk factor for colorectal cancerJournal of Coloproctology 2017; 37(1): 55 doi: 10.1016/j.jcol.2016.06.005
19
Ji-Xiang Zhang, Jia Song, Jun Wang, Wei-Guo Dong. JAK2 rs10758669 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-analysisInflammation 2014; 37(3): 793 doi: 10.1007/s10753-013-9798-5
20
Chase Cockrell, Scott Christley, Gary An, Feilim Mac Gabhann. Investigation of Inflammation and Tissue Patterning in the Gut Using a Spatially Explicit General-Purpose Model of Enteric Tissue (SEGMEnT)PLoS Computational Biology 2014; 10(3): e1003507 doi: 10.1371/journal.pcbi.1003507
21
Annibale D’Annibale, Maria C. Di Paolo, Graziano Pernazza, Vito Pende, Giorgio Lucandri, Paolo Mazzocchi, Giovanni Alfano. Atlas of Ileoscopy2013; : 141 doi: 10.1007/978-88-470-5205-5_27
22
Hao Chen, Mee Bartee, Jordan Yaron, Liying Liu, Liqiang Zhang, Donghang Zheng, Ian Hogue, Whitney Bullard, Scott Tibbetts, Alexandra Lucas. Mouse Gamma Herpesvirus MHV-68 Induces Severe Gastrointestinal (GI) Dilatation in Interferon Gamma Receptor-Deficient Mice (IFNγR−/−) That Is Blocked by Interleukin-10Viruses 2018; 10(10): 518 doi: 10.3390/v10100518
23
Stephanie C. Montgomery, Cayla M. Williams, Pinkney J. Maxwell. Nutritional Support of Patient with Inflammatory Bowel DiseaseSurgical Clinics of North America 2015; 95(6): 1271 doi: 10.1016/j.suc.2015.08.006
24
Murtaza M. Tambuwala. Natural Nuclear Factor Kappa Beta InhibitorsInflammatory Bowel Diseases 2016; 22(3): 719 doi: 10.1097/MIB.0000000000000655
25
C. C. Dias, P. P. Rodrigues, A. d. Costa-Pereira, F. Magro. Clinical Predictors of Colectomy in Patients with Ulcerative Colitis: Systematic Review and Meta-analysis of Cohort StudiesJournal of Crohn's and Colitis 2015; 9(2): 156 doi: 10.1093/ecco-jcc/jju016
26
Amit Arya, Dharam Pal Pathak, Dipak K. Majumdar, Satish Manchanda. Methacrylic acid-co-butylmethacrylate copolymers: design, characterization and evaluation as encapsulating material for colon targeted formulationsDesigned Monomers and Polymers 2016; 19(1): 34 doi: 10.1080/15685551.2015.1092011
27
Taha Rashid, Alan Ebringer, Clyde Wilson. The Role ofKlebsiellain Crohn’s Disease with a Potential for the Use of Antimicrobial MeasuresInternational Journal of Rheumatology 2013; 2013: 1 doi: 10.1155/2013/610393
28
Juan Li, Wei Zhong, Weiwei Wang, Shaoping Hu, Jiahui Yuan, Bing Zhang, Tianhui Hu, Gang Song, Lucienne Chatenoud. Ginsenoside Metabolite Compound K Promotes Recovery of Dextran Sulfate Sodium-Induced Colitis and Inhibits Inflammatory Responses by Suppressing NF-κB ActivationPLoS ONE 2014; 9(2): e87810 doi: 10.1371/journal.pone.0087810
29
Aswini  Pujahari. Unusual Cause of Colonic Obstruction: A Case ReportGastroenterology & Hepatology: Open Access 2016; 4(1) doi: 10.15406/ghoa.2016.04.00088
30
Eoin P Cummins, Glen A Doherty, Cormac T Taylor. Hydroxylases as therapeutic targets in inflammatory bowel diseaseLaboratory Investigation 2013; 93(4): 378 doi: 10.1038/labinvest.2013.9
31
Fedor V. Vityazev, Maiia I. Fedyuneva, Victoria V. Golovchenko, Olga A. Patova, Elena U. Ipatova, Eugene A. Durnev, Ekaterina A. Martinson, Sergey G. Litvinets. Pectin-silica gels as matrices for controlled drug release in gastrointestinal tractCarbohydrate Polymers 2017; 157: 9 doi: 10.1016/j.carbpol.2016.09.048
32
Jixiang Zhang, Jianhong Wu, Xiulan Peng, Jia Song, Jun Wang, Weiguo Dong, Georgina L. Hold. Associations between STAT3 rs744166 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-AnalysisPLoS ONE 2014; 9(10): e109625 doi: 10.1371/journal.pone.0109625
33
Duy Vu Le, Renuka Gupte, Meghan Hufstader Gabriel, Varun Vaidya. Inflammatory bowel disease: cost-driving factors and impact of cost sharing on outpatient resource utilizationJournal of Pharmaceutical Health Services Research 2018; 9(4): 301 doi: 10.1111/jphs.12244
34
Shelley B. Weisser, Lisa K. Kozicky, Hayley K. Brugger, Eyler N. Ngoh, Bonnie Cheung, Roger Jen, Susan C. Menzies, Asanga Samarakoon, Peter J. Murray, C. James Lim, Pauline Johnson, Jean-Luc Boucher, Nico van Rooijen, Laura M. Sly. Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammationEuropean Journal of Immunology 2014; 44(11): 3353 doi: 10.1002/eji.201343981
35
Yongchun Shen, Shujin Guo, Ting Yang, Liuqun Jia, Lei Chen, Jing An, Tao Wang, Fuqiang Wen. The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-AnalysisInternational Journal of Molecular Sciences 2013; 14(6): 11392 doi: 10.3390/ijms140611392
36
Devendra Desai. Disease Behaviour in Patients with Crohn’s Disease: A ReviewGastroenterology & Hepatology: Open Access 2015; 3(2) doi: 10.15406/ghoa.2015.03.00076
37
Ian C. Lawrance, Gerhard Rogler, Giorgos Bamias, Christine Breynaert, Jon Florholmen, Gianluca Pellino, Shimon Reif, Silvia Speca, Giovanni Latella. Cellular and Molecular Mediators of Intestinal FibrosisJournal of Crohn's and Colitis 2015; : j.crohns.2014.09.008 doi: 10.1016/j.crohns.2014.09.008
38
Fangli Yang, Danan Wang, Yan Li, Lixuan Sang, Junfeng Zhu, Jinyan Wang, Bing Wei, Changlong Lu, Xun Sun. Th1/Th2 Balance and Th17/Treg-Mediated Immunity in relation to Murine Resistance to Dextran Sulfate-Induced ColitisJournal of Immunology Research 2017; 2017: 1 doi: 10.1155/2017/7047201
39
Yu Wen Li, Ci Qiu Yang, Ying Lian Xiao, Jie Li, Chen Xi Xie, Sheng Hong Zhang, Qiao Yu, Hui Ling Wang, Wei Ming Lu, Min Hu Chen. The -A2518G polymorphism in theMCP-1gene and inflammatory bowel disease risk: A meta-analysisJournal of Digestive Diseases 2015; 16(4): 177 doi: 10.1111/1751-2980.12232
40
Yava L. Jones-Hall, Cindy H. Nakatsu. The Intersection of TNF, IBD and the MicrobiomeGut Microbes 2016; 7(1): 58 doi: 10.1080/19490976.2015.1121364
41
Trevor van Mierlo, Rachel Fournier, Richard Fedorak. Don’t Forget the Doctor: Gastroenterologists’ Preferences on the Development of mHealth Tools for Inflammatory Bowel DiseaseJMIR mHealth and uHealth 2015; 3(1): e5 doi: 10.2196/mhealth.3987
42
Gilberto Poggioli, Nicola Renzi. Ulcerative ColitisUpdates in Surgery 2019; : 17 doi: 10.1007/978-88-470-3977-3_2
43
Christine Olbjørn, Britt Nakstad, Milada C. Småstuen, Espen Thiis-Evensen, Morten H. Vatn, Gøri Perminow. Early anti-TNF treatment in pediatric Crohn’s disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patientsScandinavian Journal of Gastroenterology 2014; 49(12): 1425 doi: 10.3109/00365521.2014.966316
44
Claudia Camila Dias, Fernando Magro, Pedro Pereira Rodrigues. Preliminary Study for a Bayesian Network Prognostic Model for Crohn's Disease2015 IEEE 28th International Symposium on Computer-Based Medical Systems 2015; : 141 doi: 10.1109/CBMS.2015.40
45
Min Dai, Ting Zhang, Qianqian Li, Bota Cui, Liyuan Xiang, Xiao Ding, Rong Rong, Jianling Bai, Jianguo Zhu, Faming Zhang. The bowel preparation for magnetic resonance enterography in patients with Crohn’s disease: study protocol for a randomized controlled trialTrials 2019; 20(1) doi: 10.1186/s13063-018-3101-x
46
Talat Bessissow, Gert Van Assche. Fibrostenotic Inflammatory Bowel Disease2018; : 225 doi: 10.1007/978-3-319-90578-5_16
47
Noam Jacob, Stephan R. Targan, David Q. Shih. Fibrostenotic Inflammatory Bowel Disease2018; : 59 doi: 10.1007/978-3-319-90578-5_5
48
Kazuo Kitamura, Shinya Ashizuka, Haruhiko Inatsu, Toshihiro Kita. Innovative Medicine2015; : 227 doi: 10.1007/978-4-431-55651-0_19
49
Adi Lahat, Uri Kopylov, Sandra Neuman, Nina Levhar, Doron Yablecovitch, Benjamin Avidan, Batia Weiss, Shomron Ben-Horin, Rami Eliakim. Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn’s diseaseBMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0588-7
50
Giovanni Latella, Jacopo Di Gregorio, Vincenzo Flati, Florian Rieder, Ian C. Lawrance. Mechanisms of initiation and progression of intestinal fibrosis in IBDScandinavian Journal of Gastroenterology 2015; 50(1): 53 doi: 10.3109/00365521.2014.968863
51
Fatma S. Samman, Samah M. Elaidy, Soha S. Essawy, Mohammad S. Hassan. New insights on the modulatory roles of metformin or alpha-lipoic acid versus their combination in dextran sulfate sodium-induced chronic colitis in ratsPharmacological Reports 2018; 70(3): 488 doi: 10.1016/j.pharep.2017.11.015
52
Amandeep Singh, Neha Agrawal, Satya Kurada, Rocio Lopez, Hermann Kessler, Jessica Philpott, Bo Shen, Bret Lashner, Florian Rieder. Efficacy, Safety, and Long-term Outcome of Serial Endoscopic Balloon Dilation for Upper Gastrointestinal Crohn’s Disease-associated Strictures—A Cohort StudyJournal of Crohn's and Colitis 2017; 11(9): 1044 doi: 10.1093/ecco-jcc/jjx078
53
Lígia N.M. Ribeiro, Ana C.S. Alcântara, Margarita Darder, Pilar Aranda, Fernando M. Araújo-Moreira, Eduardo Ruiz-Hitzky. Pectin-coated chitosan–LDH bionanocomposite beads as potential systems for colon-targeted drug deliveryInternational Journal of Pharmaceutics 2014; 463(1): 1 doi: 10.1016/j.ijpharm.2013.12.035
54
Sun-Mi Yun, Seok-Ho Kim, Eun-Hee Kim. The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-ReviewFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00162
55
Usman T. Siddiqui, Hira Shahzad, Asad Jamil Raja. Pneumoperitoneum, pneumoretroperitoneum, pneumomediastinum and extensive subcutaneous emphysema in a patient with ulcerative colitis: A case reportInternational Journal of Surgery Case Reports 2015; 17: 12 doi: 10.1016/j.ijscr.2015.09.038
56
Claudia Camila Dias, Fernando Magro, Pedro Pereira Rodrigues. Disabling and Reoperation in Patients with Crohn's Disease Subject to Early Surgery or Immunosuppression: A Bayesian Network Prognostic Model2016 IEEE 29th International Symposium on Computer-Based Medical Systems (CBMS) 2016; : 265 doi: 10.1109/CBMS.2016.65
57
Ioannis Koutsounas, Emmanouil Pyleris, Panagiotis Karantanos, Charalambos Barbatzas. First Diagnosis of Inflammatory Bowel Disease in a 91-Year-Old ManCase Reports in Gastroenterology 2012; 6(3): 790 doi: 10.1159/000346467
58
Khalid A. Abdelhalim, Ataç Uzel, Nalan Gülşen Ünal. Virulence determinants and genetic diversity of adherent-invasive Escherichia coli (AIEC) strains isolated from patients with Crohn's diseaseMicrobial Pathogenesis 2020; 145: 104233 doi: 10.1016/j.micpath.2020.104233
59
Mais Khasawneh, Andrew D. Spence, Jennifer Addley, Patrick B. Allen. The role of smoking and alcohol behaviour in the management of inflammatory bowel diseaseBest Practice & Research Clinical Gastroenterology 2017; 31(5): 553 doi: 10.1016/j.bpg.2017.10.004
60
Sanja Dragasevic, Biljana Stankovic, Tomica Milosavljevic, Aleksandra Sokic-Milutinovic, Snezana Lukic, Tamara Alempijevic, Branka Zukic, Nikola Kotur, Gordana Nikcevic, Sonja Pavlovic, Dragan Popovic. Genetic and environmental factors significant for the presentation and development of inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2017; 29(8): 909 doi: 10.1097/MEG.0000000000000877